Showing articles whose micro-themes are very close to:
#molecular residual disease
- No closely related articles found yet.
- NeoGenomics Launches RaDaR ST MRD Test for HR+/HER2- Breast Cancer (neogenomics.com) | 14d ago
- NeoGenomics Launches RaDaR ST for MRD Detection Across Multiple Solid Tumors (neogenomics.com) | 14d ago
- NeoGenomics Launches RaDaR ST for Molecular Residual Disease Detection in Solid Tumors (ir.neogenomics.com) | 104d ago
- NeoGenomics Launches RaDaR ST for HPV-Negative Head and Neck Cancer MRD Detection (neogenomics.com) | 69d ago
- NeoGenomics launches PanTracer LBx liquid biopsy CGP test for advanced solid tumors (ir.neogenomics.com) | 314d ago
- NeoGenomics Launches PanTracer LBx to Expand Access to Comprehensive Genomic Profiling via Liquid Biopsy (businesswire.com) | 314d ago
- NeoGenomics Launches PanTracer LBx, a Liquid Biopsy Comprehensive Genomic Profiling Test (ir.neogenomics.com) | 314d ago
- NeoGenomics launches RaDaR ST ctDNA assay for molecular residual disease detection across solid tumor types (ir.neogenomics.com) | 104d ago
- NeoGenomics to Present Eight Abstracts at ASCO 2026 Covering MRD, NGS, and Real-World Evidence (ir.neogenomics.com) | 14d ago
- NeoGenomics to Present Eight Abstracts at ASCO 2026 Meeting (ir.neogenomics.com) | 14d ago
Showing page 1 of 1
(10 total results)
← Prev
Next →